Anbio Biotechnology posts solid FY25 results, diversifies portfolio

Anbio Biotechnology NNNN reported full-year 2025 results on Tuesday, with sales rising to $8.65 million from $8.19 million in ...
Techawk

Egyptian Biotech Startup Reme-D Secures $500,000 Funding to Scale Cold-Chain-Free Diagnostics in Africa

Reme-D, the Egyptian biotech startup, has secured $500,000 in funding from the Global Innovation Fund to expand its ...
Dallas Morning News

New McKinney biotech firm aims to integrate, simplify PCR testing

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...
KTLA

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 8, 2025 ...
WNCT

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering ...